- Home
- RMNI vs SIGA Comparison
RMNI vs SIGA Comparison
Compare RMNI & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMNI
- SIGA
- Stock Information
- Founded
- RMNI 2005
- SIGA 1995
- Country
- RMNI United States
- SIGA United States
- Employees
- RMNI N/A
- SIGA N/A
- Industry
- RMNI Business Services
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- RMNI Consumer Discretionary
- SIGA Health Care
- Exchange
- RMNI Nasdaq
- SIGA Nasdaq
- Market Cap
- RMNI 368.8M
- SIGA 422.9M
- IPO Year
- RMNI N/A
- SIGA 1997
- Fundamental
- Price
- RMNI $5.24
- SIGA $6.77
- Analyst Decision
- RMNI Buy
- SIGA
- Analyst Count
- RMNI 2
- SIGA 0
- Target Price
- RMNI $6.00
- SIGA N/A
- AVG Volume (30 Days)
- RMNI 489.2K
- SIGA 382.0K
- Earning Date
- RMNI 07-31-2025
- SIGA 07-31-2025
- Dividend Yield
- RMNI N/A
- SIGA 8.70%
- EPS Growth
- RMNI N/A
- SIGA N/A
- EPS
- RMNI N/A
- SIGA 0.67
- Revenue
- RMNI $426,212,000.00
- SIGA $120,330,310.00
- Revenue This Year
- RMNI $1.38
- SIGA N/A
- Revenue Next Year
- RMNI $3.97
- SIGA $95.31
- P/E Ratio
- RMNI N/A
- SIGA $10.28
- Revenue Growth
- RMNI N/A
- SIGA N/A
- 52 Week Low
- RMNI $1.53
- SIGA $4.95
- 52 Week High
- RMNI $5.38
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- RMNI 77.27
- SIGA 61.28
- Support Level
- RMNI $3.87
- SIGA $6.34
- Resistance Level
- RMNI $5.38
- SIGA $7.07
- Average True Range (ATR)
- RMNI 0.30
- SIGA 0.22
- MACD
- RMNI 0.15
- SIGA 0.02
- Stochastic Oscillator
- RMNI 94.08
- SIGA 71.70
About RMNI Rimini Street Inc. (DE)
Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.